TFS HealthScience and Oncomatryx Collaborate on OMTX705 Trial
06 May 2025 //
PR NEWSWIRE
Oncomatryx Raises €25 Million to Foster OMTX705 Clinical Trials
27 Jan 2025 //
BUSINESSWIRE
Oncomatryx acquires Tube Pharma to consolidate its pioneering pipeline
18 May 2023 //
BUSINESSWIRE
Oncomatryx Announces FDA and AEMPS IND Clearance for OMTX705 in Solid Tumors
31 May 2022 //
BUSINESSWIRE